North Carolina – Regional Life Sciences Roundup – October 09, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
Getting a drug to a patient takes four things: a place to make it, money to prove it, a green light to test it, and a way for people to actually get it. North Carolina covered all four this week.
Start with the factory floor. BIO’s CEO toured Biogen’s RTP campus, where about $200M of a $2B expansion has already been spent, including a new ASO purification factory. Over in Holly Springs, FUJIFILM’s Galaxy campus earned an Honorable Mention at the ISPE Facility of the Year Awards after logging more than 13 million safe work hours at an incident rate roughly 25 times better than the construction average.
Then came the money and the milestones. Wake Forest landed a five-year, $22.5M NIH renewal for its Alzheimer’s Disease Research Center, one of just 37 in the country. Treg Therapeutics brought on a funding partner to build out its non-dilutive strategy, and Dignify Therapeutics, backed by 18 NIH awards, cleared the FDA’s IND hurdle for an on-demand bowel therapy, with its first Phase 1 participant expected to be dosed in November.
Some companies are already working on the last mile. Pelthos secured a deal that brings commercial coverage of ZELSUVMI to 127 million people, Kymanox launched a Match.com for drug delivery devices, and Chilipad committed $50,000 worth of cooling sleep tech to people affected by breast cancer.
Behind all of it is the talent. The Regenerative Medicine Engine goes statewide under a new CEO, ECU’s PharmaFest put pharma employers in front of students from every major, and BioCryst built a seven-member Scientific Advisory Board of rare disease leaders. North Carolina isn’t just attracting investment, it covers the whole path from factory to patient.
Financial
Tracking the capital moving through North Carolina— funding rounds, M&A activity, and investment trends shaping NC’s life sciences companies.
Who is Helping Treg Therapeutics Fund Its Science without Giving Up Equity?
Treg Therapeutics, which is developing therapies designed to restore immune tolerance in autoimmune disease rather than simply suppress the immune system, has brought on a specialized funding partner to build out its non-dilutive strategy. By tapping government grants and other sources that don’t issue new equity, the company says it can advance key programs while keeping investor capital focused where it matters most. Find out who’s on the team. Read More >
NIH Awards $22.5 Million to Wake Forest University School of Medicine for Alzheimer’s Research
Wake Forest University School of Medicine won a five-year, $22.5 million NIH renewal for its Alzheimer’s Disease Research Center, one of just 37 in the national network and now a decade old. The center studies how everyday conditions like obesity, diabetes, high blood pressure, and physical inactivity may raise Alzheimer’s risk, supports 160+ grants, and has already moved its early-detection screening methods into Advocate Health primary care clinics. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Geraint Parfitt named the Study Director of Powered Research
Geraint Parfitt, Ph.D., spent more than 15 years on the sponsor side buying preclinical studies, and now he’s running them as the new Study Director at Powered Research, a CRO focused only on ophthalmology. At OASIS Medical he built a new research facility and took eye-care products from concept to launch, and at AbbVie he led retinal pharmacology teams and gene therapy and biologics pipelines. The pitch is that sponsors now get their data from someone who knows exactly what an IND submission demands. Read More >
Kimberly J. Clinical Promoted to Site ID Lead at Fortrea
Fortrea expanded Kimberly Johnson’s role from Clinical Team Lead into a hybrid Site ID Lead position, focusing on the critical bridge from feasibility to site activation. The move positions a seasoned trial manager directly upstream to resolve operational bottlenecks before site startup begins. Johnson noted the role allows her to mitigate potential risks and build early momentum across clinical sites. Read More >
Spotlighting 100 Women In Tech 2026
A new 100 Women in FinTech report, created with Parity in partnership with LSEG, recognizes the founders, executives, engineers, and investors building financial technology. Honorees include leaders from companies such as Adyen, Fireblocks, Green Dot, and Zip Co. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across North Carolina’s life sciences and biotech employers.
NC’s Regenerative Medicine Engine Goes Statewide, and a Former Defense Department Health Leader Is Taking the Wheel
Regenerative medicine, the field of therapies that help the body repair or regrow its own cells, tissues, and organs, is getting a statewide push. The Engine helped bring seven new regenerative medicine companies to North Carolina in 2025 and reports $270M in economic activity and 721 new jobs since launch. Startups can use a free prototyping test bed in Winston-Salem, regulatory guidance, and a single contract covering multiple IRB reviews, and Lester Martinez, MD, the former Assistant Secretary of Defense for Health Affairs, becomes CEO on November 1. Read More >
NC Commerce Awards Grants To Local Workforce Boards for Employer Engagement
Gov. Josh Stein announced $660,000 in employer engagement grants to 13 local workforce boards, including the Capital Area board covering Wake, Orange, Chatham, Johnston and Lee counties and Kerr-Tar in the northern Triangle. The money will fund efforts to partner with local businesses, including work-based learning and apprenticeships, in support of the state’s goal of engaging 50,000 employers as talent pipeline partners. Read More >
Who’s hiring?!
Top Employer
Operating as a global CDMO under Tokyo-based FUJIFILM Holdings Corporation, this biomanufacturing partner advances biologics, vaccines, and cell or gene therapies. Backed by 5,000 global personnel throughout North America, Europe, and Asia, their teams handle everything from cell line design to full commercial-scale production.
Anchor facilities in RTP and Holly Springs drive the company’s regional presence. The newly launched $3.2B Holly Springs hub stands as North America’s largest end-to-end cell culture facility, featuring eight 20,000L bioreactors initially, with plans to expand capacity even further while scaling local headcount to 1,400 over the coming years.
They are currently hiring across 20+ roles in the North Carolina region. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Eurofins BioPharma Service (Durham, NC) is hiring a Environmental Monitoring Specialist | Apply Now >
- Becton Dickinson (Durham, NC) is hiring a Senior Manager- RxAuto Communications | Apply Now >
- IQVIA (Durham, NC) is hiring a Principal Biostatistian FSP, RWE | Apply Now >
- Fortrea (East Coast) is hiring a FSP Sr. Clinical Research Associate- East Coast- Ophthalmology | Apply Now >
- Viiv HealthCare (Durham, NC) is hiring a Senior Director, Early Development Leader | Apply Now >
- Baxter International Inc (Raleigh, NC) is hiring a Critical Account Lead | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across North Carolina.
Mooresville’s Chilipad Partners With National Breast Cancer Foundation to Bring Better Sleep to People Affected by Breast Cancer
Mooresville-based Chilipad launched a year-long partnership with the National Breast Cancer Foundation, committing $50,000 worth of its water-based cooling sleep technology to men and women affected by breast cancer, since treatment can bring hot flashes and night sweats that wreck sleep. A limited-edition pink remote ring will send all proceeds to NBCF, and Charlotte breast cancer survivor Katy Harrel will help tell the story during Breast Cancer Awareness Month. Read More >
Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® bringing Commercial Coverage to 127 Million People
Pelthos Therapeutics signed a deal with one of the largest U.S. pharmacy benefit managers, which covers roughly one in three Americans, to add ZELSUVMI® to its national formulary with no prior authorization, bringing commercial coverage to 127 million lives (69%) and Medicaid coverage to 100% of covered lives. It matters because molluscum contagiosum affects an estimated 16.7 million people in the U.S., and up to 73% of children with the infection go untreated. ZELSUVMI is the first and only prescription therapy approved for home use. Read More >
Morrisville’s Kymanox Launches a ‘Match.com’ for Drug Delivery Devices
Morrisville-based Kymanox launched KymaBridge™, a searchable platform that lets pharma and biotech sponsors compare autoinjectors, pen injectors, on-body injectors, inhalers, and more in one place, with each listing reviewed by Kymanox experts and confirmed by the device supplier. The company says it’s the only place where device data is verified by both sides, a big deal in an industry where scattered documentation has been the norm. Read More >
An RTP Startup’s On-Demand Bowel Therapy Just Got FDA Clearance for Human Testing
Dignify Therapeutics, based at the First Flight Venture Center in RTP, received FDA clearance for its IND for DTI-117, a short-acting peptide injection designed to trigger controlled bowel emptying within minutes in people with neurogenic bowel dysfunction. The Phase 1 healthy volunteer trial is expected to dose its first participant in November, with early data in 2027. The effort is backed by 18 NIH awards (more than $20M in NIH funding), the NC Biotechnology Center, and the One NC Small Business Program. Read More >
Ecosystem
The partnerships, programs, and policy moves building North Carolina’s life sciences infrastructure — and the organizations driving it forward.
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
BioCryst has formed a seven-member Scientific Advisory Board to guide pipeline expansion and its push toward external innovation. It is chaired by Tony Manning, Ph.D., who as CSO of Momenta built the pipeline behind nipocalimab (IMAAVY), now FDA-approved for generalized myasthenia gravis and warm autoimmune hemolytic anemia. The board also includes Teva’s Chief Medical Officer, Eric Hughes, M.D., Ph.D., and Christine Bulawa, Ph.D., who played a key role in the early development of tafamidis, the first drug treatment for transthyretin amyloidosis.
ECU PharmaFest to connect residents with pharmaceutical companies
ECU’s Eastern Region Pharma Center hosted PharmaFest on October 8, a free career event that let regional pharma employers recruit students and alumni from every academic major, not just the sciences. It’s aimed at eastern NC’s BioPharma Crescent, home to Thermo Fisher, Novo Nordisk, Grifols, and Pfizer, where companies partnering with the center are investing roughly $3B across the region. NCBiotech puts the average salary in NC’s life sciences industry at about $121,000. Read More >
BIO on the American Road Spotlights North Carolina’s Biotech Boom with RTP Visit
BIO CEO John Crowley brought a delegation to Research Triangle Park on October 2 and toured Biogen’s RTP manufacturing campus. Biogen says about $200M of its $2B expansion has been spent this year, including a new antisense oligonucleotide (ASO) purification factory, and it is weighing more investment based on its late-stage portfolio. Crowley said RTP shows “the power of bringing innovation, investment and manufacturing together.” Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in NC biotech and life sciences this week.
Inside FUJIFILM Biotechnologies’ 2026 ISPE Facility of the Year Awards (FOYA) Honorable Mention Project: Galaxy
FUJIFILM Biotechnologies’ nearly one-million-square-foot Holly Springs campus earned an Honorable Mention at the 2026 ISPE Facility of the Year Awards. Robots printed the floorplan resulting in a safety record 25x better than average. This was accomplished by copying their own blueprint and by using a “design once, build many” approach that produced a first design model about 75% accurate, cut engineering costs by 50%, and delivered more than 13 million safe work hours with an incident rate roughly 25 times better than the construction average.
Licensing a Molecule from China? What U.S. Biotechs Need to Evaluate First
China is now a major source of innovative drug candidates, often developed faster and at lower cost than comparable Western programs, according to Verta Life Sciences, and U.S. biotechs are licensing them through ex-China deals that hand over rights to the U.S., EU, and beyond. But the article’s warning is blunt: Chinese manufacturing and data practices, while often scientifically sound, don’t always map onto FDA and EMA documentation standards, and closing that gap is typically the single biggest driver of timeline and cost. Without a ready supply chain, even a well-documented molecule can stall before it reaches a single patient. Read More >
Is Animal Testing on Its Way Out? Not Quite, but the Regulatory Playbook Is Being Rewritten
Premier Research breaks down how New Approach Methodologies (NAMs) and Model-Informed Drug Development (MIDD) are being combined to build stronger, more human-relevant evidence before a drug reaches patients, backed by new 2026 FDA and ICH guidance. The real-world examples are the hook: modeling helped cut extra studies for ibrutinib and oseltamivir, and predicted cytokine release risk for the bispecific mosunetuzumab before first-in-human dosing. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across North Carolina’s life sciences ecosystem that you don’t want to miss.
Triangle Biotech Event at Chrysalis
Tuesday, October 13, 2026 • 5:30 PM –7:30 PM • Chrysalis RTP, NC
Hosted by Triangle Biotech | Register Now >
Miracle Road: The Story of RTP Launch and Book Signing
Tuesday, October 13, 2026 • 3:00 PM –6:30 PM • Durham, NC
Hosted by North Carolina Biotechnology Center | Register Now >
NC Life Sciences Live Career Fair
Tuesday, October 20, 2026 • 2:00 PM –6:00 PM • Durham, NC
Hosted by NC BioNetwork | Register Now >
Did we miss something!? Drop us a line →
Stay connected to North Carolina’s Region life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the North Carolina Region Roundup every Friday.
The week’s most important life sciences news from the NC region— delivered to your inbox.
